CATALAYER NEWS

FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka - Fierce Pharma

Source: Fierce Pharma · 2026-07-07
FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka Fierce Pharma
RELATED ON CATALAYER
Mentioned Tickers
$TGT · Target$NVS · Novartis
Related Topics
Biotech & FDA NewsRetail & E-commerce News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?51%New Playboi Carti Album before GTA VI?50%Will Jesus Christ return before GTA VI?50%
Open Catalayer terminal for live tracking →